Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II double cord blood transplantation after reduced-intensity conditioning in adults lacking a matched unrelated donor
2008-000053-35Phase 2Completed
- Sponsor
- Erasmus MC
- Start
- May 2008
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cord blood unit in hematopoietic malignancies, sponsored by Erasmus MC. Primary endpoint: Cumulative incidence of graft failure. Started May 2008; status: completed.
02
Drugs
cord blood unit
03
Conditions
hematopoietic malignancies
Beyond the preview
Go deeper on 2008-000053-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000053-35.